- NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)
- Immunovia carries out a rights issue of units of approximately SEK 70 million and raises bridge loans
- Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
- Immunovia publishes the annual report for 2023
- Immunovia Publishes Interim Report for January-March 2024
- Invitation to Immunovia's Q1 presentation
- Immunovia announces updated financial calendar
- Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
- Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study
More ▼
Key statistics
On Tuesday, Immunovia AB (publ) (IMMNOV:STO) closed at 1.44, 179.38% above the 52 week low of 0.514 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.42 |
---|---|
High | 1.49 |
Low | 1.42 |
Bid | 1.44 |
Offer | 1.47 |
Previous close | 1.47 |
Average volume | 198.21k |
---|---|
Shares outstanding | 45.29m |
Free float | 34.65m |
P/E (TTM) | -- |
Market cap | 64.76m SEK |
EPS (TTM) | -6.06 SEK |
Data delayed at least 15 minutes, as of Jun 04 2024 17:00 BST.
More ▼